German med schools perfectly OK with pharma-rep visits and gifts

German med school deans aren't too concerned with pharma reps swaying their students' future prescription habits, according to a recent survey. The findings: Only two of 30 responding universities had created guidelines for staff and students on dealing with pharma companies, and only 6 said they desired those guidelines. "That's a remarkably low number," one study conductor said. "We're behind the U.S. on this by 10 to 15 years." More

Suggested Articles

Dupixent has been posting strong sales growth for Sanofi, and now the drugmaker has a third FDA indication to keep the momentum going.

Acadia Pharmaceuticals is taking Parkinson’s disease education on the road in a partnership with the Michael J. Fox Foundation.

AbbVie continues its long-running aggressive TV ad push for Humira last month, while Gilead Sciences takes two spots in the top 10 tally from iSpot.